Importation of Italian-authorized Cisatracurio Hikma 2 mg/mL Ampoules due to the Current Shortage of Canadian-authorized Cisatracurium Omega
Importation of Italian-authorized Cisatracurio Hikma 2 mg/mL Ampoules due to the Current Shortage of Canadian-authorized Cisatracurium Omega
Recalling Firm: Marketed health products
Reason for Recall / Hazard
Packaging - Product safety - Supply
Product Description & Identification
Importation of Italian-authorized Cisatracurio Hikma 2 mg/mL Ampoules due to the Current Shortage of Canadian-authorized Cisatracurium Omega
Affected Products
Cisatracurio Hikma 2 mg/mL Ampoules
Additional Source Details
| Field | Value |
|---|---|
| N I D | 75277 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/importation-italian-authorized-cisatracurio-hikma-2-mgml-ampoules-due-current-shortage |
| Issue | Packaging - Product safety - Supply |
| Title | Importation of Italian-authorized Cisatracurio Hikma 2 mg/mL Ampoules due to the Current Shortage of Canadian-authorized Cisatracurium Omega |
| Product | Cisatracurio Hikma 2 mg/mL Ampoules |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2024-04-24 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Importation of Italian-authorized Cisatracurio Hikma 2 mg/mL Ampoules due to the Current Shortage of Canadian-authorized Cisatracurium Omega Check if your household is affected: https://therecallfile.com/recalls/importation-of-italian-authorized-cisatracurio-hikma-2-mg-ml-ampoules/CANADA-75277
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.